Watch These Eli Lilly Stock Price Levels as Weight-Loss Drug Competition Rises [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
possible impact of a promising new weight-loss injection developed by Viking Therapeutics on the drugmaker's own anti-obesity drug, Mounjaro. The stock's technicals, including bearish divergence and a decisive close beneath a multi-month uptrend line and the 50-day moving average, point to a potential reversal. Eli Lilly shares may encounter support on the chart from prior price action at $790, $725, and $625. A bars pattern, extracting the trending move from April to July and applies it from Thursday's low, projects an upside price target of around $1,060. Eli Lilly ( LLY ) shares dropped more than 4% on Thursday, continuing a hasty retreat from their record high earlier this month, as investors assessed the possible impact of a promising new weight-loss injection developed by Viking Therapeutics ( VKTX ) on the drugmaker's own weigh anti-obesity drug, Mounjaro. Last week, Eli Lilly shares tumbled after Swiss pharmaceutical firm Roche Holding AG said its new non-injectable we
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know [Yahoo! Finance]Yahoo! Finance
- Several Factors Negatively Impacted Viking Therapeutics (VKTX) in Q2 [Yahoo! Finance]Yahoo! Finance
- Viking Surges 342% in the Past Year: How Should You Play the Stock? [Yahoo! Finance]Yahoo! Finance
- The Best Biotech Stock to Invest $1,000 in Right Now [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: GLP-1/GIP Receptor Agonist And Its Competitive Landscape [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 7/24/24 - Beat
VKTX
Sec Filings
- 8/22/24 - Form 4
- 8/22/24 - Form 4
- 8/21/24 - Form 144
- VKTX's page on the SEC website